Amalgamated Bank’s Vertex Pharmaceuticals Inc Position
Does Amalgamated Bank own Vertex Pharmaceuticals Inc (VRTX)? Yes — 53.3K shares worth $24M (+0.18% of its 13F portfolio) as of Q1 2026, down from 55.1K shares the prior filed quarter.
Position Value
$24M
Q1 2026
Shares
53.3K
% of Portfolio
+0.18%
Quarters Held
29
currently held
Position History VRTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 53.3K | $24M | +0.18% |
| Q4 2025 | 55.1K | $25M | +0.18% |
| Q3 2025 | 56.5K | $22M | +0.16% |
| Q2 2025 | 55.7K | $25M | +0.19% |
| Q1 2025 | 53.7K | $26M | +0.22% |
| Q4 2024 | 53.0K | $21M | +0.18% |
| Q3 2024 | 56.2K | $26M | +0.22% |
| Q2 2024 | 53.8K | $25M | +0.21% |
| Q1 2024 | 55.6K | $23M | +0.20% |
| Q4 2023 | 64.5K | $26M | +0.21% |
| Q3 2023 | 68.2K | $24M | +0.20% |
| Q2 2023 | 76.5K | $27M | +0.22% |
| Q1 2023 | 81.1K | $26M | +0.22% |
| Q4 2022 | 69.9K | $20M | +0.18% |
| Q3 2022 | 75.7K | $22M | +0.21% |
| Q2 2022 | 69.1K | $19M | +0.18% |
| Q1 2022 | 69.4K | $18M | +0.14% |
| Q4 2021 | 71.2K | $16M | +0.12% |
| Q3 2021 | 65.3K | $12M | +0.10% |
| Q2 2021 | 67.9K | $14M | +0.11% |
| Q1 2021 | 16.0K | $3M | +0.13% |
| Q4 2020 | 16.7K | $4M | +0.15% |
| Q3 2020 | 16.8K | $5M | +0.20% |
| Q2 2020 | 17.3K | $5M | +0.23% |
| Q1 2020 | 43.4K | $10M | +0.25% |
| Q4 2019 | 44.4K | $10M | +0.18% |
| Q3 2019 | 42.6K | $7M | +0.15% |
| Q2 2019 | 34.0K | $6M | +0.15% |
| Q1 2019 | 38.4K | $7M | +0.17% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Amalgamated Bank’s full portfolio or all institutional holders of VRTX.